Pituitary gland volume among heroin users stabilised on substitution pharmacotherapy

Drug Alcohol Depend. 2010 Jul 1;110(1-2):164-6. doi: 10.1016/j.drugalcdep.2010.02.012. Epub 2010 Mar 19.

Abstract

While long-term heroin addiction is associated with hypothalamus-pituitary-adrenal (HPA) axis dysregulation, few studies have used in vivo brain imaging to examine the impact on pituitary gland volume (PGV) or its relationship with substitution pharmacotherapy. We examined 28 heroin users stable on methadone or buprenorphine and 28 healthy controls. Heroin users exhibited larger PGVs than healthy controls, and this was particularly evident among the buprenorphine-treated group. These findings indicate that substitution pharmacotherapy may have differential effects on normalising HPA axis activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Buprenorphine / therapeutic use*
  • Female
  • Heroin Dependence / pathology*
  • Heroin Dependence / psychology
  • Heroin Dependence / rehabilitation*
  • Humans
  • Male
  • Methadone / therapeutic use*
  • Narcotic Antagonists / therapeutic use*
  • Narcotics / therapeutic use*
  • Neuropsychological Tests
  • Pituitary Gland / pathology*
  • Psychiatric Status Rating Scales
  • Socioeconomic Factors

Substances

  • Narcotic Antagonists
  • Narcotics
  • Buprenorphine
  • Methadone